학술논문
A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects: comment
Document Type
Correspondence
Author
Source
In Journal of Thrombosis and Haemostasis October 2017 15(10):2080-2081
Subject
Language
ISSN
1538-7836